IFN ALPHA SUBTYPE HYBRID
European patent · EP3116530 · Deleted
Register entry
- Publication number
- EP3116530
- Application number
- EP15712186
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 12, 2015
- Published
- Jan 18, 2017
- Granted
- Sep 23, 2020
- Deleted
- Oct 23, 2026
- Reason
- Annual fee unpaid
- IPC classes
- A61K 38/21 (2006.01)A61K 39/35 (2006.01)A61P 1/00 (2006.01)A61P 35/00 (2006.01)A61P 37/00 (2006.01)A61P 37/08 (2006.01)
- Priority
- GB 201404403 12.03.2014
- PCT application
- PCT/GB2015/050717 12.03.2015
- PCT publication
- WO2015/136287 17.09.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 23, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.10.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.10.2026
- Aug 27, 2025
Next annual fee due on
- Next annual fee due on
- 31.03.2025 → 31.03.2026
Published in Swissreg on 27.08.2025
- Apr 1, 2024
Change
Published in Swissreg on 01.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- May 27, 2021
Address changed
- Representative
- Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève → Murgitroyd & Company, 4, Rue du Commerce, 1204 Genève
Published in Swissreg on 27.05.2021
- Dec 18, 2020
Agent entered
- Representative
- Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève
Published in Swissreg on 18.12.2020
- Sep 23, 2020
Granted
Published in Swissreg on 23.09.2020
Parties
Holder
ILC Therapeutics Ltd
Newhouse Lanarkshire ML1 5UH, GB
Agent
Murgitroyd & Company
1204 Genève
Inventor
STIMSON, William
Glasgow G62 6HG, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.